Abingworth LLP Hille Vax, Inc. Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
A detailed history of Abingworth LLP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Abingworth LLP holds 1,838,486 shares of HLVX stock, worth $3.84 Million. This represents 10.2% of its overall portfolio holdings.
Number of Shares
1,838,486
Previous 1,838,486
-0.0%
Holding current value
$3.84 Million
Previous $31.4 Million
2.05%
% of portfolio
10.2%
Previous 10.74%
Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
7Shares Held
4.16MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Xtx Topco LTD London, X0179KShares$374,4940.02% of portfolio
-
Tekla Capital Management LLC27KShares$56,4290.02% of portfolio
-
Credit Suisse Ag Zurich, V815.7KShares$32,7870.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ10.9KShares$22,6910.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.